JP2002514594A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002514594A5 JP2002514594A5 JP2000547972A JP2000547972A JP2002514594A5 JP 2002514594 A5 JP2002514594 A5 JP 2002514594A5 JP 2000547972 A JP2000547972 A JP 2000547972A JP 2000547972 A JP2000547972 A JP 2000547972A JP 2002514594 A5 JP2002514594 A5 JP 2002514594A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- alkyl
- animal
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 11
- 239000011669 selenium Substances 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000005313 fatty acid group Chemical class 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000000546 pharmaceutic aid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- -1 tetradecyl seleno Chemical group 0.000 description 1
Description
【特許請求の範囲】
【請求項1】
一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される脂肪酸類似体又はその塩の、肥満の予防用の医薬組成物を調製するための使用。
【請求項2】
m≧13である、請求項1に記載の使用。
【請求項3】
xがイオウである、請求項1に記載の使用。
【請求項4】
xがセレンである、請求項1に記載の使用。
【請求項5】
動物における肥満又は過体重状態の予防のための、請求項1に記載の使用。
【請求項6】
前記動物がヒトである、請求項5に記載の使用。
【請求項7】
前記動物が、キジ類のトリ、ウシ、ヒツジ、ヤギ又はブタ哺乳動物を含む農業用動物である、請求項5に記載の使用。
【請求項8】
前記動物が、イヌ又はネコを含む家畜又は愛玩動物である、請求項5に記載の使用。
【請求項9】
前記動物が、サケ、タラ、テラピア、ハマグリ、カキ、ロブスター又はカニを含む魚貝類である、請求項5に記載の使用。
【請求項10】
前記医薬組成物が、前記脂肪酸類似体又はその塩の予防的に有効な濃度がその投与の期間に動物の血中に実質的に持続的に維持されるように投与されるものとして意図されていることを特徴とする、請求項1に記載の使用。
【請求項11】
前記医薬組成物が単位剤形であることを特徴とする、請求項1に記載の使用。
【請求項12】
一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される新規な脂肪酸類似体又はその塩。
【請求項13】
動物における肥満の予防のための医薬組成物であって、前記医薬組成物が、一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される脂肪酸類似体又はその塩を含む医薬組成物。
【請求項14】
前記医薬組成物が脂肪酸類似体と混和物の形で製剤学的に許容される担体又は賦形剤を含む、請求項13に記載の医薬組成物。
【請求項15】
m≧13である、請求項13に記載の医薬組成物。
【請求項16】
xがイオウである、請求項13に記載の医薬組成物。
【請求項17】
xがセレンである、請求項13に記載の医薬組成物。
【請求項1】
一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される脂肪酸類似体又はその塩の、肥満の予防用の医薬組成物を調製するための使用。
【請求項2】
m≧13である、請求項1に記載の使用。
【請求項3】
xがイオウである、請求項1に記載の使用。
【請求項4】
xがセレンである、請求項1に記載の使用。
【請求項5】
動物における肥満又は過体重状態の予防のための、請求項1に記載の使用。
【請求項6】
前記動物がヒトである、請求項5に記載の使用。
【請求項7】
前記動物が、キジ類のトリ、ウシ、ヒツジ、ヤギ又はブタ哺乳動物を含む農業用動物である、請求項5に記載の使用。
【請求項8】
前記動物が、イヌ又はネコを含む家畜又は愛玩動物である、請求項5に記載の使用。
【請求項9】
前記動物が、サケ、タラ、テラピア、ハマグリ、カキ、ロブスター又はカニを含む魚貝類である、請求項5に記載の使用。
【請求項10】
前記医薬組成物が、前記脂肪酸類似体又はその塩の予防的に有効な濃度がその投与の期間に動物の血中に実質的に持続的に維持されるように投与されるものとして意図されていることを特徴とする、請求項1に記載の使用。
【請求項11】
前記医薬組成物が単位剤形であることを特徴とする、請求項1に記載の使用。
【請求項12】
一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される新規な脂肪酸類似体又はその塩。
【請求項13】
動物における肥満の予防のための医薬組成物であって、前記医薬組成物が、一般式(I):
CH3−[CH2]m−x−CH 2 −COOR
(式中、mは0乃至23の整数であり、
xは、S及びSeを含む群から選択され、
Rは水素又はC1−C4アルキルである)で示される脂肪酸類似体又はその塩を含む医薬組成物。
【請求項14】
前記医薬組成物が脂肪酸類似体と混和物の形で製剤学的に許容される担体又は賦形剤を含む、請求項13に記載の医薬組成物。
【請求項15】
m≧13である、請求項13に記載の医薬組成物。
【請求項16】
xがイオウである、請求項13に記載の医薬組成物。
【請求項17】
xがセレンである、請求項13に記載の医薬組成物。
BH4 −
4.アルキル−Se−Se−アルキル ⇒ 2アルキル−Se−
5.アルキル−Se − + Hal−CH 2 −COOH ⇒ アルキル−Se−CH2−COOH
例えば、アルキルがテトラデシルであるときの最終化合物、(CH3−(CH2)13−Se−CH2−COOH(テトラデシルセレノ酢酸(TSA))は、ジエチルエーテル及びヘキサンからの結晶化により精製することができる。この産物は、NMR、IR及び分子量測定法により完全に特徴づけられうる。
4.アルキル−Se−Se−アルキル ⇒ 2アルキル−Se−
5.アルキル−Se − + Hal−CH 2 −COOH ⇒ アルキル−Se−CH2−COOH
例えば、アルキルがテトラデシルであるときの最終化合物、(CH3−(CH2)13−Se−CH2−COOH(テトラデシルセレノ酢酸(TSA))は、ジエチルエーテル及びヘキサンからの結晶化により精製することができる。この産物は、NMR、IR及び分子量測定法により完全に特徴づけられうる。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NONO9800143 | 1998-05-08 | ||
PCT/NO1998/000143 WO1999058120A1 (en) | 1998-05-08 | 1998-05-08 | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
NO9800143 | 1998-05-08 | ||
PCT/NO1999/000135 WO1999058121A1 (en) | 1998-05-08 | 1999-04-23 | Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2002514594A JP2002514594A (ja) | 2002-05-21 |
JP2002514594A5 true JP2002514594A5 (ja) | 2012-03-01 |
JP5057003B2 JP5057003B2 (ja) | 2012-10-24 |
Family
ID=19907879
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000547972A Expired - Fee Related JP5057003B2 (ja) | 1998-05-08 | 1999-04-23 | 肥満、高血圧及び脂肪肝の治療用の新規な脂肪類似体 |
JP2000547973A Pending JP2002514595A (ja) | 1998-05-08 | 1999-04-23 | 糖尿病の治療用の新規な脂肪類似体 |
JP2000547974A Expired - Fee Related JP4465672B2 (ja) | 1998-05-08 | 1999-05-07 | 再狭窄の治療及び/又は予防用の医薬組成物並びにそれを調製するためのttaの使用 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000547973A Pending JP2002514595A (ja) | 1998-05-08 | 1999-04-23 | 糖尿病の治療用の新規な脂肪類似体 |
JP2000547974A Expired - Fee Related JP4465672B2 (ja) | 1998-05-08 | 1999-05-07 | 再狭窄の治療及び/又は予防用の医薬組成物並びにそれを調製するためのttaの使用 |
Country Status (18)
Country | Link |
---|---|
US (4) | US6365628B1 (ja) |
EP (5) | EP1075259B1 (ja) |
JP (3) | JP5057003B2 (ja) |
KR (3) | KR100701503B1 (ja) |
CN (3) | CN1223343C (ja) |
AT (5) | ATE336239T1 (ja) |
AU (4) | AU7240398A (ja) |
BR (2) | BR9910296A (ja) |
CA (3) | CA2331395C (ja) |
DE (5) | DE69932864D1 (ja) |
DK (3) | DK1075259T3 (ja) |
ES (3) | ES2204142T3 (ja) |
HK (3) | HK1034909A1 (ja) |
NO (3) | NO20005463L (ja) |
NZ (3) | NZ508047A (ja) |
PT (2) | PT1075259E (ja) |
RU (3) | RU2219920C2 (ja) |
WO (4) | WO1999058120A1 (ja) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
AU784588B2 (en) * | 1999-09-17 | 2006-05-04 | Peplin Biolipids Pty Ltd | Anti-inflammatory nitro- and thia- fatty acids |
WO2001037827A1 (en) * | 1999-10-13 | 2001-05-31 | Chacon Marco A | Therapeutic intervention to mimic the effect of caloric restriction |
NO328803B1 (no) * | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
NO20003591L (no) * | 2000-07-13 | 2002-01-14 | Thia Medica As | Fettsyreanaloger for behandling av kreft |
NO20006008L (no) | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
DE10115740A1 (de) * | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
US6908632B1 (en) | 2002-04-19 | 2005-06-21 | Pharmanex, Llc | Blood glucose modulating compositions and methods |
DK1547614T3 (da) * | 2002-05-28 | 2011-04-04 | Ajinomoto Kk | Medicinsk sammensætning til inhibering af ekspressionen af ATP-citrat-lyase og anvendelse deraf |
JP5008258B2 (ja) | 2002-06-20 | 2012-08-22 | アイシー・ベック・リミテッド | 含硫黄ホスホリピド誘導体 |
US20080200453A1 (en) | 2002-07-29 | 2008-08-21 | Cincotta Anthony H | Methods of treating metabolic syndrome using dopamine receptor agonists |
US9655865B2 (en) | 2002-07-29 | 2017-05-23 | Veroscience, Llc | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
US20040220190A1 (en) * | 2002-07-29 | 2004-11-04 | Cincotta Anthony H. | Methods of treating metabolic syndrome using dopamine receptor agonists |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
US20040081678A1 (en) * | 2002-08-09 | 2004-04-29 | Anthony Cincotta | Therapeutic process for the treatment of obesity and associated metabolic disorders |
US7045547B2 (en) * | 2002-08-20 | 2006-05-16 | University Of Delaware | Acyl-CoA dehydrogenase allenic inhibitors |
RU2005106274A (ru) | 2002-09-06 | 2005-11-10 | Янссен Фармацевтика, Н.В. (Be) | Гетероциклические соединения |
AU2003272738B2 (en) * | 2002-09-27 | 2010-04-01 | Martek Biosciences Corporation | Docosahexaenoic acid for improved glycemic control |
KR20050071565A (ko) * | 2002-10-10 | 2005-07-07 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 지방 알콜의 염기성 에스테르 및 이들의 항염증제 또는면역조절제로서의 용도 |
FR2850650B1 (fr) * | 2003-01-31 | 2005-03-25 | Genfit S A | Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures |
FR2850869B1 (fr) * | 2003-02-12 | 2005-03-25 | Genfit S A | Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures |
US7705016B2 (en) | 2003-02-13 | 2010-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus |
CN1934072A (zh) * | 2004-01-30 | 2007-03-21 | 派普林生物脂股份有限公司 | 治疗和载体分子 |
US20050215558A1 (en) * | 2004-03-25 | 2005-09-29 | Cincotta Anthony H | Methods of identifying responders to dopamine agonist therapy |
US8137993B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
US8137994B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
CN1961213A (zh) * | 2004-05-28 | 2007-05-09 | 詹森药业有限公司 | 新的在清醒大鼠中静脉给药和血液取样模型 |
DE102004034640A1 (de) | 2004-07-16 | 2006-02-16 | Institut für Molekular- und Systemmedizin | Verfahren zur systemischen Biokorrektur eines Organismus |
NZ553261A (en) * | 2004-07-19 | 2010-12-24 | Thia Medica As | Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
NO324534B1 (no) * | 2004-07-19 | 2007-11-19 | Thia Medica As | Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og en planteolje eller fiskeolje samt anvendelser derav |
WO2006041922A2 (en) * | 2004-10-08 | 2006-04-20 | Dara Biosciences, Inc. | Agents and methods for administration to the central nervous system |
US7288525B2 (en) * | 2004-12-28 | 2007-10-30 | The Research Foundation Of State University Of New York | Method for lowering serum homocysteine |
WO2006088798A2 (en) * | 2005-02-14 | 2006-08-24 | Albert Einstein College Of Medicine Of Yeshiva University | Modulation of hypothalamic atp-sensitive potassium channels |
BRPI0611159A2 (pt) * | 2005-05-04 | 2012-07-31 | Pronova Biopharma Norge As | composto e respectivo processo e fabrico, composiÇÕes farmacÊutica e de Ácido graxo, usos de composto e mÉtodos de controle da reduÇço do peso corpàreo e/ou prevenÇço do ganho de peso corpàreo, de tratamento e/ou prevenÇço da obesidade ou de uma condiÇço de sobrepeso, do diabete, de doenÇas relacionadas com a amiloidose, de tratamento ou profilaxia de fatores méltiplos de risco para doenÇas cardiovasculares e de prevenÇço do derrame cerebral, de ataques isquÊmicos cerebrais ou passageiros relacionados com a aterosclerose de vÁrias artÉrias |
US7586003B2 (en) * | 2005-07-14 | 2009-09-08 | Zinpro Corporation | Derivatives of seleno-amino acids |
NO20053519L (no) * | 2005-07-18 | 2007-01-19 | Thia Medica As | Anvendelse av forbindelser som omfatter fettsyrer |
NO20055541L (no) * | 2005-11-23 | 2007-05-24 | Berge Biomed As | Use of fatty acid analogues |
GB0605900D0 (en) * | 2006-03-23 | 2006-05-03 | Lipigen As | Modulators of nuclear receptors |
US20080085293A1 (en) * | 2006-08-22 | 2008-04-10 | Jenchen Yang | Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor |
EP2083817A4 (en) * | 2006-10-20 | 2009-12-23 | Cpd Llc | METHOD FOR RECONSTRUCTING THE EFFECT OF INCRETIN |
KR101544584B1 (ko) * | 2006-11-01 | 2015-08-13 | 프로노바 바이오파마 너지 에이에스 | 오메가-3 지질 화합물 |
CA2667211A1 (en) * | 2006-11-01 | 2008-05-08 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
WO2008106092A1 (en) * | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses |
EP2117301A4 (en) * | 2007-02-26 | 2010-04-14 | Yeda Res & Dev | USE OF LONG-CHAINED ALCOHOL DERIVATIVES FOR THE TREATMENT OF CIRCULAR HAIR LOSS |
EP2214481B1 (en) | 2007-10-15 | 2019-05-01 | United Animal Health, Inc. | Method for increasing performance of offspring |
US20100267828A1 (en) * | 2007-10-31 | 2010-10-21 | Anne Kristin Holmeide | dha derivatives and their use as medicaments |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
CA2722114A1 (en) * | 2008-04-29 | 2009-11-05 | F. Hoffmann-La Roche Ag | 4-trimethylammonio-butyrates as cpt2 inhibitors |
EP2147910A1 (en) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
WO2010033878A2 (en) | 2008-09-19 | 2010-03-25 | David Brown | Solute concentration measurement device and related methods |
MX366137B (es) | 2009-05-08 | 2019-06-28 | Pronova Biopharma Norge As | Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios. |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
AU2010278894B2 (en) | 2009-07-30 | 2014-01-30 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US20130209550A1 (en) | 2010-07-28 | 2013-08-15 | Life Technologies Corporation | Anti-Viral Azide Containing Compounds |
US20120028335A1 (en) | 2010-07-28 | 2012-02-02 | Life Technologies Corporation | Anti-viral azide-containing compounds |
JP2014505017A (ja) | 2010-11-05 | 2014-02-27 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 脂質化合物を用いる処置方法 |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
GB201301626D0 (en) * | 2013-01-30 | 2013-03-13 | Dignity Sciences Ltd | Composition comprising 15-OHEPA and methods of using the same |
AU2014222389B2 (en) | 2013-02-28 | 2018-11-29 | Pronova Biopharma Norge As | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same |
CA2904898C (en) | 2013-03-11 | 2019-10-15 | Jan Remmereit | Lipid compositions containing bioactive fatty acids |
CA2904827C (en) | 2013-03-11 | 2020-10-27 | Life Science Nutrition As | Natural lipids containing non-oxidizable fatty acids |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
RU2522224C1 (ru) * | 2013-08-06 | 2014-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная академия ветеринарной медицины" | Способ лечения острого гепатоза у кошек |
WO2016073615A1 (en) | 2014-11-07 | 2016-05-12 | Regents Of The University Of Minnesota | Salts and compositions useful for treating disease |
JP6784696B2 (ja) | 2015-04-28 | 2020-11-11 | プロノヴァ バイオファーマ ノルゲ エーエス | 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び/又は治療のための使用 |
US10492141B2 (en) | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
US10792266B2 (en) | 2017-10-23 | 2020-10-06 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
BR112020011431A2 (pt) | 2017-12-06 | 2020-11-24 | Basf As | derivados de ácido graxo para o tratamento de esteato-hepatite não alcoólica |
EP3934639A4 (en) * | 2019-03-04 | 2023-01-11 | Epitracker, Inc. | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE DISORDERS, BEHAVIORAL DISORDERS AND CHRONIC PAIN |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59175425A (ja) * | 1983-03-25 | 1984-10-04 | Otsuka Pharmaceut Co Ltd | 脳卒中予防剤 |
GB8813012D0 (en) * | 1988-06-02 | 1988-07-06 | Norsk Hydro As | Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals |
US6063581A (en) * | 1992-01-22 | 2000-05-16 | Axis-Shield Asa | Immunoassay for homocysteine |
US6197789B1 (en) * | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
-
1998
- 1998-05-08 WO PCT/NO1998/000143 patent/WO1999058120A1/en active Application Filing
- 1998-05-08 AU AU72403/98A patent/AU7240398A/en not_active Abandoned
-
1999
- 1999-04-23 AT AT02024616T patent/ATE336239T1/de not_active IP Right Cessation
- 1999-04-23 CA CA002331395A patent/CA2331395C/en not_active Expired - Fee Related
- 1999-04-23 ES ES99933293T patent/ES2204142T3/es not_active Expired - Lifetime
- 1999-04-23 EP EP99933293A patent/EP1075259B1/en not_active Expired - Lifetime
- 1999-04-23 DE DE69932864T patent/DE69932864D1/de not_active Expired - Lifetime
- 1999-04-23 KR KR1020007012282A patent/KR100701503B1/ko not_active IP Right Cessation
- 1999-04-23 DK DK99933293T patent/DK1075259T3/da active
- 1999-04-23 BR BR9910296-0A patent/BR9910296A/pt not_active IP Right Cessation
- 1999-04-23 JP JP2000547972A patent/JP5057003B2/ja not_active Expired - Fee Related
- 1999-04-23 AT AT02024388T patent/ATE334666T1/de not_active IP Right Cessation
- 1999-04-23 EP EP02024388A patent/EP1284139B1/en not_active Expired - Lifetime
- 1999-04-23 US US09/700,062 patent/US6365628B1/en not_active Expired - Lifetime
- 1999-04-23 US US09/700,061 patent/US6441036B1/en not_active Expired - Lifetime
- 1999-04-23 DK DK99933292T patent/DK1075258T3/da active
- 1999-04-23 AU AU49366/99A patent/AU762792B2/en not_active Ceased
- 1999-04-23 JP JP2000547973A patent/JP2002514595A/ja active Pending
- 1999-04-23 NZ NZ508047A patent/NZ508047A/en not_active IP Right Cessation
- 1999-04-23 PT PT99933293T patent/PT1075259E/pt unknown
- 1999-04-23 AT AT99933292T patent/ATE247464T1/de not_active IP Right Cessation
- 1999-04-23 KR KR1020007012281A patent/KR100701502B1/ko not_active IP Right Cessation
- 1999-04-23 EP EP99933292A patent/EP1075258B1/en not_active Expired - Lifetime
- 1999-04-23 RU RU2000131222/15A patent/RU2219920C2/ru not_active IP Right Cessation
- 1999-04-23 PT PT99933292T patent/PT1075258E/pt unknown
- 1999-04-23 CN CNB998059684A patent/CN1223343C/zh not_active Expired - Fee Related
- 1999-04-23 BR BR9910297-8A patent/BR9910297A/pt not_active Application Discontinuation
- 1999-04-23 RU RU2000131221/14A patent/RU2221558C2/ru not_active IP Right Cessation
- 1999-04-23 DE DE69932645T patent/DE69932645D1/de not_active Expired - Lifetime
- 1999-04-23 WO PCT/NO1999/000136 patent/WO1999058122A1/en active IP Right Grant
- 1999-04-23 CN CNB998059668A patent/CN1245157C/zh not_active Expired - Fee Related
- 1999-04-23 CA CA002331408A patent/CA2331408C/en not_active Expired - Fee Related
- 1999-04-23 EP EP02024616A patent/EP1285652B1/en not_active Expired - Lifetime
- 1999-04-23 AT AT99933293T patent/ATE245416T1/de not_active IP Right Cessation
- 1999-04-23 ES ES99933292T patent/ES2207253T3/es not_active Expired - Lifetime
- 1999-04-23 NZ NZ508045A patent/NZ508045A/en not_active IP Right Cessation
- 1999-04-23 DE DE69909775T patent/DE69909775T2/de not_active Expired - Lifetime
- 1999-04-23 AU AU49367/99A patent/AU762790B2/en not_active Ceased
- 1999-04-23 DE DE69910559T patent/DE69910559T2/de not_active Expired - Lifetime
- 1999-04-23 WO PCT/NO1999/000135 patent/WO1999058121A1/en active IP Right Grant
- 1999-05-07 AT AT99940723T patent/ATE306916T1/de not_active IP Right Cessation
- 1999-05-07 US US09/674,982 patent/US6417232B1/en not_active Expired - Lifetime
- 1999-05-07 NZ NZ508046A patent/NZ508046A/en not_active IP Right Cessation
- 1999-05-07 DE DE69927805T patent/DE69927805T2/de not_active Expired - Fee Related
- 1999-05-07 DK DK99940723T patent/DK1075260T3/da active
- 1999-05-07 RU RU2000131220/15A patent/RU2223095C2/ru not_active IP Right Cessation
- 1999-05-07 KR KR1020007012283A patent/KR100822077B1/ko not_active IP Right Cessation
- 1999-05-07 CA CA002331393A patent/CA2331393C/en not_active Expired - Fee Related
- 1999-05-07 AU AU54517/99A patent/AU761355B2/en not_active Ceased
- 1999-05-07 CN CNB998059676A patent/CN1244323C/zh not_active Expired - Fee Related
- 1999-05-07 EP EP99940723A patent/EP1075260B1/en not_active Expired - Lifetime
- 1999-05-07 ES ES99940723T patent/ES2251218T3/es not_active Expired - Lifetime
- 1999-05-07 JP JP2000547974A patent/JP4465672B2/ja not_active Expired - Fee Related
- 1999-05-07 WO PCT/NO1999/000149 patent/WO1999058123A2/en active IP Right Grant
-
2000
- 2000-10-30 NO NO20005463A patent/NO20005463L/no not_active Application Discontinuation
- 2000-10-30 NO NO20005462A patent/NO333143B1/no not_active IP Right Cessation
- 2000-10-30 NO NO20005461A patent/NO20005461L/no not_active Application Discontinuation
-
2001
- 2001-08-14 HK HK01105684A patent/HK1034909A1/xx not_active IP Right Cessation
- 2001-08-14 HK HK01105689A patent/HK1034911A1/xx not_active IP Right Cessation
- 2001-08-14 HK HK01105690A patent/HK1034912A1/xx not_active IP Right Cessation
-
2002
- 2002-05-17 US US10/151,203 patent/US7026356B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002514594A5 (ja) | ||
RU2000131222A (ru) | Новые аналоги жирных кислот для лечения ожирения, гипертензии и жировой инфильтрации печени | |
AU2689699A (en) | Small molecules that increase the conversion of food to body weight gain | |
CA2058754C (en) | Divalent metal salts of indomethacin | |
JPS6312043B2 (ja) | ||
JP2007515402A5 (ja) | ||
CA2235902C (en) | Method for treating protozoal infections | |
JPH0359882B2 (ja) | ||
WO2007142707A1 (en) | Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals | |
RU2005104894A (ru) | Способ повышения мясной продуктивности молодняка свиней на откорме | |
US7045150B2 (en) | Tellurium containing nutrient formulation and process for enhancing the cumulative weight gain or feed efficacy in poultry | |
JP3534792B2 (ja) | 抗病性飼料 | |
US20190191740A1 (en) | Methods to Promote Growth and Improve Feed Conversion in Animals | |
EP0407405A1 (en) | Method for treating hoof thrush and hoof rot | |
CA1072013A (en) | Method of enhancing reproductive efficiency in non-human animals | |
JP2011182748A (ja) | 家畜又は家禽用飼料 | |
JPS6324858A (ja) | 動物飼料 | |
JP4629964B2 (ja) | ウシの消化器疾患治療剤 | |
WO2002003813A1 (en) | Use of dammarane-type triterpenoid saponins | |
Murray | Effect of insulin, adrenal cortical hormones, salt and dl-alanine on carbohydrate metabolism in scurvy. | |
JPWO2007037098A1 (ja) | 繁殖障害改善剤 | |
JP2005501008A5 (ja) | ||
RU2005140156A (ru) | Применение аивлозина для лечения болезней, вызванных brachyspira pilosicoli или ornithobacterium rhinotracheale | |
JP3981770B2 (ja) | 抗ロタウイルス剤、及びその用途 | |
JP3014784B2 (ja) | 魚類のストレス防止用薬剤 |